Chronic neutrophilic leukaemia.

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Chronic neutrophilic leukaemia (CNL) is a rare myeloproliferative neoplasm (MPN).
• CNL is defined by sustained high white blood cell counts with mature neutrophil proliferation.
• Unlike other MPNs, CNL lacks common genetic mutations like JAK2 or BCR-ABL1.

Purpose of the Study:

• To review the clinical, morphological, and pathobiological aspects of CNL.
• To discuss the differential diagnosis of CNL.
• To explore the implications of CSF3R mutations in CNL pathogenesis and treatment.

Main Methods:

• Review of existing literature on CNL.
• Analysis of clinical findings and diagnostic criteria.
• Examination of molecularpathology, focusing on CSF3R mutations.

Main Results:

• CNL is characterized by sustained leukocytosis and neutrophil proliferation without typical MPN mutations.
• Mutations in the colony-stimulating factor 3 receptor (CSF3R) are frequently identified in CNL patients.
• CSF3R mutations provide significant insights into CNL pathogenesis.

Conclusions:

• CSF3R mutations are a key discovery in understanding CNL.
• This finding opens new avenues for targeted therapies in CNL.
• Further research into CSF3R is crucial for improving CNL patient outcomes.